Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(38%)
Results Posted
50%(2 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
1
13%
Ph not_applicable
3
38%
Ph phase_1
2
25%
Ph phase_3
2
25%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Active, not recruiting2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 32 (25.0%)
Phase 41 (12.5%)
N/A3 (37.5%)

Trials by Status

completed450%
recruiting113%
active_not_recruiting225%
terminated113%

Recent Activity

3 active trials
Showing 5 of 8
active_not_recruitingphase_3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

NCT04963296
recruitingnot_applicable

Histamines and Central Hemodynamics

NCT07285031
active_not_recruitingphase_3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

NCT05627557
completednot_applicable

Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers

NCT01204255
completedphase_4

Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness

NCT02578186
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04963296Phase 3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

Active Not Recruiting
NCT07285031Not Applicable

Histamines and Central Hemodynamics

Recruiting
NCT05627557Phase 3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

Active Not Recruiting
NCT01204255Not Applicable

Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers

Completed
NCT02578186Phase 4

Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness

Completed
NCT00223691Phase 1

Treatment of Orthostatic Hypotension in Autonomic Failure

Completed
NCT00000875Not Applicable

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Terminated
NCT00662337Phase 1

Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8